News
The latest oncology news stories provided by Elsevier Global Medical News and FDC Reports
Multiple Melanomas in the Same Patient a Real Phenomenon
Elsevier Global Medical News. 2010 Feb 5, D Brunk
Restarting Gefitinib Draws Responses After Treatment Failure in NSCLC
Elsevier Global Medical News. 2010 Feb 3, S London
Clinical Judgment Key in Evaluating Longitudinal Melanonychia Severity
Elsevier Global Medical News. 2010 Feb 3, D Brunk
CME
Stay current and earn valuable credits by participating in customized online programs
Breast Cancer: A 67-Year-Old Woman With a Recently Identified, Palpable Left Breast Mass
An interactive, case-based CME program provided by MedCases
Leukemia: CML Patients Resistant to First-Line Therapies
An interactive, case-based CME program provided by MedCases
Review Articles
Peruse thousands of cancer-specific review articles, most with full-text downloadable PDFs
Barrett's Esophagus and Esophageal Adenocarcinoma
Nature Reviews Cancer. 2010 Feb 1;(10):87-101, BJ Reid, et al
Paraneoplastic Syndromes in Patients With Oral Cancer
Oral Oncol. 2010 Jan;46(1):14-18, C Toro, et al
Journal Scans
The top cancer-related articles from leading journals selected by medical experts
Long-Term Survival With Autotransplantation for Multiple Myeloma
J Clin Oncol. 2010 Jan 19;Epub ahead of print, B Barlogie, et al
Irinotecan Regimens for Metastatic Colorectal Cancer in the Elderly
Am J Geriatr Pharmacother. 2009 Dec 1;7(6):343-354, NA Obeidat, et al
Viewpoints
Opinions and insights from key opinion leaders and the front lines of care
SABCS 2009: Potentially Practice-Changing Studies
2010 Jan 25, Lee Schwartzberg, MD, Editor-in-Chief
Cancer Policy Forum
Behind-the-headlines perspectives from COA on the politics of cancer
Health Care Reform Hits a Brown Wall
Community Oncology Alliance. 2010 Jan 25, Patrick Cobb, MD; Ted Okon
The Health Care Reform Fight: Abortion and the Public Plan, Before the Final Bell
Community Oncology Alliance. 2009 Dec 11, Patrick Cobb, MD; Ted Okon
Sign up for our newsletters
Too busy to follow cancer's top stories? Sign-up for 1 or more of our free newsletters -- delivered weekly to your inbox.Advisory and Editorial Boards
Meet OncologySTAT's Advisory and Editorial Boards that represent community practitioners and academic specialists with cross-disciplinary expertise.Latest Commentary
Results of significant adjuvant hormonal therapy studies will help shape the standard of care for 2009.
Editors' Choice
Neoadjuvant Trastuzumab improves event-free survival in HER2+ locally advanced or inflammatory breast cancer.
